| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/07/2005 | US20050075382 Compounds as bactericides or drugs |
| 04/07/2005 | US20050075379 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/07/2005 | CA2744997A1 C-met modulators and method of use |
| 04/07/2005 | CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/07/2005 | CA2539042A1 Gamma-secretase inhibitors |
| 04/07/2005 | CA2538694A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | CA2537877A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 04/07/2005 | CA2537010A1 Phenyl - carboxamide compounds useful for treating pain |
| 04/07/2005 | CA2537004A1 Therapeutic agents useful for treating pain |
| 04/06/2005 | EP1519929A1 2,1,3-benzothiadiazoles for use as electronic active components |
| 04/06/2005 | EP1519924A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519921A2 Substituted anthranilic amide derivatives and methods of use |
| 04/06/2005 | EP1465882A4 Hetrocyclic modulators of nuclear receptors |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | CN1604897A 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 04/06/2005 | CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/06/2005 | CN1603323A Process for preparing 5-[[4-[2-(5- ethyl-2- pyridyl) ethoxy] phenyl] methyl]-2, 4- thiazolidinedione |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875790 Viricides |
| 04/05/2005 | US6875784 Bactericides; grampositive, gramnegative bacteria |
| 04/05/2005 | US6875778 Substituted with pyridinylmethyl-, oxazolylmethyl-, imidazolylmethyl-, or thiazolylmethyl- groups |
| 04/05/2005 | US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 04/05/2005 | US6875770 Antiinflamamtory agents; side effect reduction |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875761 Certain 1,3-disubstituted isoquinoline derivatives |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 03/31/2005 | WO2005028473A1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
| 03/31/2005 | WO2005028467A1 Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
| 03/31/2005 | WO2005028457A1 Preparation of quetiapine |
| 03/31/2005 | WO2005028456A1 Thiazole derivatives as cannabinoid receptor modulators |
| 03/31/2005 | WO2005028448A1 Benzyl-benzimidazolyl derivatives |
| 03/31/2005 | WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/31/2005 | WO2005028443A2 Protein tyrosine kinase enzyme inhibitors |
| 03/31/2005 | WO2005028440A1 Novel gamma secretase inhibitors |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2003073987A3 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070718 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/31/2005 | US20050070706 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070588 Imidazolyl inhibitors of 15-lipoxygenase |
| 03/31/2005 | US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 03/31/2005 | US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 03/31/2005 | US20050070570 6,8-Dimethoxy isoquinoline derivatives; useful in the treatment or alleviation of disorders and conditions associated with, or dependent on membrane potential or conductance of cells in mammals, including humans, such as asthma, cystic fibrosis, obstructive pulmonary disease, convulsions, vascular spasms |
| 03/31/2005 | US20050070562 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/31/2005 | US20050070538 Compounds and uses thereof in modulating amyloid beta |
| 03/31/2005 | US20050070535 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070534 Non-peptidic NPY Y2 receptor inhibitors |
| 03/31/2005 | US20050070533 Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 03/31/2005 | US20050070531 Using such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile to treat cancer and/or autoimmune disorder |
| 03/31/2005 | US20050070530 Dipeptidyl peptidase inhibitors |
| 03/31/2005 | US20050070520 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 03/31/2005 | US20050070439 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 03/31/2005 | US20050069522 Combination pharmaceutical agents as inhibitors of HCV replication |
| 03/31/2005 | CA2539848A1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
| 03/31/2005 | CA2539554A1 Phenylacetic acid derivative, process for producing the same, and use |
| 03/31/2005 | CA2538855A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/31/2005 | CA2538590A1 Novel gamma secretase inhibitors |
| 03/30/2005 | EP1519237A2 Organophotoreceptor with charge transport compound with an azine group |
| 03/30/2005 | EP1519235A2 Linked dihydrazone-based charge transport compounds |
| 03/30/2005 | EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay |
| 03/30/2005 | EP1518855A1 Diaminopyrimidinecarboxa mide derivative |
| 03/30/2005 | EP1517899A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 03/30/2005 | EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 03/30/2005 | EP1517895A1 8-(biaryl) quinoline pde4 inhibitors |
| 03/30/2005 | EP1517685A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 03/30/2005 | EP1264826B1 Novel imidazoline compounds |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/30/2005 | EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders |
| 03/30/2005 | EP0877740B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 03/30/2005 | CN1602311A Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 03/30/2005 | CN1602310A Benzothiazoles compound |
| 03/30/2005 | CN1602308A Thiophene derivatives used as antiviral agent against flavivirus infections |